iu ny s gip bn trnh n qu nhiu v n vt
Both tirzepatide and retatrutide represent a major shift in how medical weight loss and metabolic health are being approached
Those two conflicting theories are illustrated in Fig
Propionate, produced by Akkermansia, has been shown to reduce activity in brain reward centers associated with high-calorie food cravings in human functional MRI studies
27 Importantly, GLP-1 action is short-lived, with a half-life of just 12 minutes in the bloodstream under normal physiological conditions, after which it is broken down by the enzyme dipeptidyl peptidase IV (DPP-4), resulting in a loss of its biological activity
Structure Therapeutics: GSBR-1290 [60] [61] [60] [61] An oral GLP1R agonist, currently being studied in a double-blinded, placebo-controlled Phase 2a clinical trial